JBJS - 2026-10-01 - Journal Article
Temporal Macrophage Activation Is Reduced by CCR2 Knockout in a Murine Subacromial Impingement Model.
Covello MR, Carballo CB, Pedaprolu K, Yao VJH, Ranga S, Piacentini A, Suzuki Y, Okazaki Y, Bowen E, Babich JW, Kelly JM, Rodeo SA, Eliasberg CD
Topics
Key Takeaway
CCR2 knockout reduces peak macrophage activation at days 3 and 7 post-subacromial impingement and attenuates histologic tendinopathic changes, but confers no biomechanical advantage over wild-type at 42 days.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This study characterized the temporal macrophage inflammatory profile in a murine subacromial impingement model and tested whether CCR2 knockout alters that response. Sixty-four mice underwent subacromial clip placement or sham surgery and were assessed with microPET/CT using gallium-68-labeled folate receptor ligand, gene expression profiling, histology, and biomechanical testing. WT mice showed reproducible macrophage activation peaking at days 3 and 7 with early M1-dominant gene upregulation transitioning to M2 markers; CCR2KO reduced this early activation and histologic degeneration but did not improve tendon biomechanical properties at day 42.
Key Limitation
The absence of biomechanical improvement in CCR2KO tendons despite reduced inflammation suggests that attenuating early macrophage activation alone is insufficient for structural tendon recovery, limiting direct translational applicability of CCR2 inhibition as a standalone therapeutic strategy.
Original Abstract
BACKGROUND
Rotator cuff (RC) tendinopathy is a prevalent cause of shoulder pain and disability, yet its underlying molecular drivers remain poorly defined. Increasing evidence highlights the role of early inflammation and macrophage activation in symptom development and disease progression. C-C chemokine receptor 2 (CCR2) regulates monocyte recruitment and pro-inflammatory macrophage signaling in tendinopathy. This study characterizes the temporal inflammatory profile of RC tendinopathy and evaluates the impact of CCR2 knockout in a murine subacromial impingement (SAI) model.
METHODS
Sixty mice (40 C57BL/6J wild type [WT SAI] and 20 CCR2 knockout [CCR2KO]) underwent bilateral placement of a subacromial surgical clip to induce RC impingement. Four additional C57BL/6J mice underwent sham surgery (WT sham controls). Animals were assessed through 42 days. Macrophage activation was quantified using microPET/CT (micro-positron emission tomography/computed tomography) and gallium-68-labeled folate receptor ligand. Selected WT SAI mice were killed at early and intermediate time points for temporal gene expression profiling. The remaining mice were killed on day 42 for histological, biomechanical, or gene expression analyses.
RESULTS
WT SAI mice demonstrated a reproducible pattern of early macrophage activation, peaking on postoperative days 3 and 7. CCR2KO mice exhibited significantly reduced macrophage activation at these time points. Gene expression analysis of WT SAI supraspinatus tendons revealed early upregulation of inflammatory and M1 macrophage-related genes, followed by later increases in anti-inflammatory mediators and M2 macrophage-related markers. CCR2KO tendons demonstrated fewer tendinopathic changes on histology but did not exhibit superior biomechanical properties compared with WT SAI tendons.
CONCLUSIONS
RC tendinopathy exhibits a distinct early inflammatory phase characterized by macrophage activation and M1 macrophage-dominant signaling. CCR2KO reduces early inflammatory activity and may attenuate tendon degeneration.
CLINICAL RELEVANCE
Defining the inflammatory progression of RC disease may help to refine treatment strategies-particularly the use and timing of nonsteroidal anti-inflammatory drugs, corticosteroid injections, and emerging biologic therapies. CCR2 represents a potential therapeutic target for modulating early inflammation and improving tendon healing.